three activated upstream regulators are cigarette smoke (z-score = 2.577), benzo [a]pyrene (z-score = 2.905), and nuclear factor (erythroid-derived 2)-like 2 (NFE2L2, Nrf2) (z-score = 2.531). Analysis of downstream effects indicated that growth of epithelial tissue was predicted to be increased (z-score = 2.813; P , 0.001). The top three canonical pathways included xenobiotic metabolism signaling, aryl hydrocarbon receptor signaling, and nicotine degradation III.
Rationale: Evidence has shown that inhaled lung carcinogens, such as tobacco smoke, silica, or asbestos, induce a T-helper cell type 17 inflammatory environment. Interleukin-17A (commonly and hereafter called is the signature cytokine of T-helper cell type 17 inflammation. We have shown previously that IL-17 overexpression promotes growth of lung adenocarcinoma in transgenic mouse models. Our additional findings suggest that IL-17 suppresses the function of the p53 tumor suppressor protein in a mutant K-Ras-expressing lung tumor cell line.
Objectives:
To compare our studies in mice to clinical samples.
Methods:
We have used informatics and RNA sequencing-based approaches to analyze primary human lung adenocarcinoma samples.
Results: Comprehensive transcriptome analyses have shown that IL-17 expression positively correlates with expression of serine/ arginine-rich splicing factor 1 (SRSF1), a key cellular splicing factor. This observation correlates with our previous finding that IL-17 regulates the activity of serine/argininerich splicing factor 1. In accord, there are significant differences in the global splicing activity between the IL-17 1 and IL-17 2 lung adenocarcinomas, indicating that IL-17 may affect the selectivity of RNA splicing events by targeting serine/argininerich splicing factor 1. Further, Ingenuity pathway analyses (Qiagen) have identified activation of key pathways in IL-17 1 relative to IL17 2 lung adenocarcinomas. In these analyses, IL-18 signaling appears central to IL-17 1 lung adenocarcinomas, which display prominent signatures related to inflammation and evasion of antitumor immunity.
Conclusions: Our RNA sequencing-based transcriptome analyses of lung adenocarcinomas have identified a cohort of patients that may be good candidates for immune therapy.
Keywords: lung adenocarcinoma; IL-17A; lung inflammation; K-Ras; T-helper cell type 17 inflammation Conclusions: To our knowledge, this is the first study to suggest CIH increases macrophage matrix metalloproteinase 12 expression in mice. Combined exposures to WTC dust and CIH further increased macrophage matrix metalloproteinase 12 expression. Given the role of matrix metalloproteinase 12 in pulmonary fibrosis and chronic obstructive pulmonary disease pathogenesis, patients with obstructive sleep apnea who have been exposed to WTC dust may have added risk for pulmonary parenchymal disease.
Keywords: disasters; toxicology; immunology; sleep apnea syndromes Detrimental effects of air pollution with fine dust (particulate matter <2.5 mm in aerodynamic diameter, or PM 2.5 ) on the systemic circulation and the left heart have been studied intensely during the past decade. In comparison, knowledge regarding the effects of exposure to air pollution with PM 2.5 on the pulmonary vasculature and the right heart lags far behind. A report on severe lung disease and right heart failure in coal miners was published nearly 170 years ago. However, today, we still do not have a clear picture of how the effect of air pollution on the pulmonary circulation or the right heart should be viewed from a clinical, mechanistic biological, therapeutic, or economic angle.
In the laboratory, we have established a model of immune response-induced vascular remodeling that is significantly worsened by adding PM 2.5 to the intranasal antigen challenge solution. Importantly, the PM 2.5 is given at a concentration that by itself does not induce significant inflammation or pulmonary vascular remodeling. However, when added to antigen, this low-dose PM 2.5 exposure induces severe pulmonary vascular remodeling, significantly increased right ventricular pressures, and significant molecular changes in the right heart. Our data also show that these PM 2.5 -exaggerated responses are dependent on interleukin-13, interleukin-17A, and antigen-specific antibody. The experimental model is being used to address a few questions: 1. Which mechanism protects the animals from severe right ventricular failure despite the severity of the pulmonary artery remodeling? 2. What is the mechanism by which PM 2.5 worsens the response to antigen? 3. How does PM 2.5 exert its effects across the small airways to the small blood vessels?
In conclusion, further investigation is urgently needed to understand the effects of exposure to ambient or occupational air pollution on the pulmonary vasculature, because better knowledge could lead to immediate beneficial actions for patients with pulmonary hypertension and persons at risk.
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